1. Home
  2. SYRE vs NATL Comparison

SYRE vs NATL Comparison

Compare SYRE & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$32.90

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$39.14

Market Cap

2.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYRE
NATL
Founded
2013
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
SYRE
NATL
Price
$32.90
$39.14
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
$56.50
$42.75
AVG Volume (30 Days)
795.0K
353.9K
Earning Date
02-26-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.74
Revenue
N/A
$4,322,000,000.00
Revenue This Year
N/A
$2.83
Revenue Next Year
N/A
$3.96
P/E Ratio
N/A
$22.94
Revenue Growth
N/A
0.63
52 Week Low
$10.91
$22.30
52 Week High
$35.31
$42.23

Technical Indicators

Market Signals
Indicator
SYRE
NATL
Relative Strength Index (RSI) 56.96 50.80
Support Level $30.00 $39.08
Resistance Level $34.21 $41.01
Average True Range (ATR) 1.89 1.08
MACD 0.00 0.00
Stochastic Oscillator 81.16 53.33

Price Performance

Historical Comparison
SYRE
NATL

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

Share on Social Networks: